Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a minor site update rather than changes to the study details.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page template. This appears to be a backend maintenance update rather than new visible content.SummaryDifference0.0%

- Check34 days agoChange DetectedNew help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' label was standardized and the footer revision text updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new release of the page. No substantive content changes are indicated by this update.SummaryDifference0.0%

- Check55 days agoChange DetectedThe sponsor on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, updating the record to reflect the current sponsor responsible for the trial.SummaryDifference0.2%

- Check62 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.3 to v3.5.4, signaling a minor version update of the platform. This change does not modify the displayed study information or navigation.SummaryDifference0.0%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.